NSG BioLabs partners with EnterpriseSG and Merck to boost biotech industry

It also secured US$14.5m in strategic funding.

NSG BioLabs, Singapore’s premier provider of biotech laboratory and office space, has teamed up with Enterprise Singapore (EnterpriseSG) and Merck to propel the biotech sector.

The partnerships aim to provide essential resources like funding, expertise, and networks to support startup research and development.

Additionally, NSG BioLabs has secured a US$14.5m financing round, led by Celadon Partners and ClavystBio.

Since 2019, NSG BioLabs has been instrumental in assisting over 40 companies, including multinationals and startups, in achieving significant milestones and securing nearly US$400m in funding.

“NSG BioLabs is committed to supporting innovators and proud to have helped in Singapore's growing biotech ecosystem,” said Daphne Teo, CEO and Founder of NSG BioLabs. “Our partnerships with EnterpriseSG and Merck signify the importance of a collaborative spirit, and we hope to spur greater collaboration among other stakeholders to benefit the biotech industry in Singapore and the Asia Pacific region.”

The renewed partnership with EnterpriseSG will focus on nurturing high-potential biotech startups, particularly in precision medicine, whilst the collaboration with Merck will provide NSG BioLabs residents with special access to reagents, equipment, and expertise.

Follow the link for more news on

NSG BioLabs

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia